2-Chloro-n-[4-(3,4-dimethylphenyl)-1,3-thiazol-2-yl]acetamide

Catalog No.: 
ACXLPI145
CAS No.: 
565165-38-0
Molecular Formula: 
C13H13ClN2OS
Molecular Weight: 
280.78
2-Chloro-n-[4-(3,4-dimethylphenyl)-1,3-thiazol-2-yl]acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$66.00InquiryInquiry
100mg95%$89.00InquiryInquiry
250mg95%$117.00InquiryInquiry
1g95%$216.00InquiryInquiry
5g95%$808.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-n-[4-(3,4-dimethylphenyl)-1,3-thiazol-2-yl]acetamide
IUPAC Name2-chloro-N-(4-(3,4-dimethylphenyl)thiazol-2-yl)acetamide
MDL No.MFCD03423373
Molecular FormulaC13H13ClN2OS
Molecular Weight280.78
SMILESCC1=CC=C(C=C1C)C1=CSC(NC(=O)CCl)=N1
InChI KeyZDPNZGLZYQVPDD-UHFFFAOYSA-N
Synonym2-CHLORO-N-[4-(3,4-DIMETHYLPHENYL)-1,3-THIAZOL-2-YL]ACETAMIDE;ZINC02569087;Acetamide, 2-chloro-N-[4-(3,4-dimethylphenyl)-2-thiazolyl]-
CAS No.565165-38-0

Synthetic Route by SureRoute

1. ACXLPI145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNWPR180 route compound structure diagram
    ACNWPR1802633-50-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLPI145 route product structure diagram
    ACXLPI145565165-38-0
Inquiry

2. ACXLPI145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLPI145 route product structure diagram
    ACXLPI145565165-38-0
Inquiry

3. ACXLPI145 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLPI145 route product structure diagram
    ACXLPI145565165-38-0
Inquiry

Comments (0)